249 related articles for article (PubMed ID: 19912506)
1. The relationship of testosterone to prostate-specific antigen in men with sexual dysfunction.
Corona G; Boddi V; Lotti F; Gacci M; Carini M; De Vita G; Sforza A; Forti G; Mannucci E; Maggi M
J Sex Med; 2010 Jan; 7(1 Pt 1):284-92. PubMed ID: 19912506
[TBL] [Abstract][Full Text] [Related]
2. Serum PSA as a predictor of testosterone deficiency.
Rastrelli G; Corona G; Vignozzi L; Maseroli E; Silverii A; Monami M; Mannucci E; Forti G; Maggi M
J Sex Med; 2013 Oct; 10(10):2518-28. PubMed ID: 23859334
[TBL] [Abstract][Full Text] [Related]
3. ANDROTEST: a structured interview for the screening of hypogonadism in patients with sexual dysfunction.
Corona G; Mannucci E; Petrone L; Balercia G; Fisher AD; Chiarini V; Forti G; Maggi M
J Sex Med; 2006 Jul; 3(4):706-715. PubMed ID: 16839327
[TBL] [Abstract][Full Text] [Related]
4. Different testosterone levels are associated with ejaculatory dysfunction.
Corona G; Jannini EA; Mannucci E; Fisher AD; Lotti F; Petrone L; Balercia G; Bandini E; Chiarini V; Forti G; Maggi M
J Sex Med; 2008 Aug; 5(8):1991-8. PubMed ID: 18399946
[TBL] [Abstract][Full Text] [Related]
5. Hysterical traits are not from the uterus but from the testis: a study in men with sexual dysfunction.
Bandini E; Corona G; Ricca V; Fisher AD; Lotti F; Sforza A; Faravelli C; Forti G; Mannucci E; Maggi M
J Sex Med; 2009 Aug; 6(8):2321-31. PubMed ID: 19493294
[TBL] [Abstract][Full Text] [Related]
6. The effect of statin therapy on testosterone levels in subjects consulting for erectile dysfunction.
Corona G; Boddi V; Balercia G; Rastrelli G; De Vita G; Sforza A; Forti G; Mannucci E; Maggi M
J Sex Med; 2010 Apr; 7(4 Pt 1):1547-56. PubMed ID: 20141585
[TBL] [Abstract][Full Text] [Related]
7. Prostatic specific antigen in patients with hypogonadism: effect of testosterone replacement.
El-Sakka AI; Hassoba HM; Elbakry AM; Hassan HA
J Sex Med; 2005 Mar; 2(2):235-40. PubMed ID: 16422891
[TBL] [Abstract][Full Text] [Related]
8. Prostate-specific antigen (PSA) concentrations in hypogonadal men during 6 years of transdermal testosterone treatment.
Raynaud JP; Gardette J; Rollet J; Legros JJ
BJU Int; 2013 May; 111(6):880-90. PubMed ID: 23294726
[TBL] [Abstract][Full Text] [Related]
9. Subjective sexual response to testosterone replacement therapy based on initial serum levels of total testosterone.
Reyes-Vallejo L; Lazarou S; Morgentaler A
J Sex Med; 2007 Nov; 4(6):1757-62. PubMed ID: 17087806
[TBL] [Abstract][Full Text] [Related]
10. Prostate-specific antigen changes in hypogonadal men treated with testosterone replacement.
Gerstenbluth RE; Maniam PN; Corty EW; Seftel AD
J Androl; 2002; 23(6):922-6. PubMed ID: 12399540
[TBL] [Abstract][Full Text] [Related]
11. The response to testosterone undecanoate in men with type 2 diabetes is dependent on achieving threshold serum levels (the BLAST study).
Hackett G; Cole N; Bhartia M; Kennedy D; Raju J; Wilkinson P; Saghir A;
Int J Clin Pract; 2014 Feb; 68(2):203-15. PubMed ID: 24355040
[TBL] [Abstract][Full Text] [Related]
12. The relationship between testosterone and sexual function in depressed and healthy men.
Rizvi SJ; Kennedy SH; Ravindran LN; Giacobbe P; Eisfeld BS; Mancini D; McIntyre RS
J Sex Med; 2010 Feb; 7(2 Pt 1):816-25. PubMed ID: 19796059
[TBL] [Abstract][Full Text] [Related]
13. Psychobiologic correlates of the metabolic syndrome and associated sexual dysfunction.
Corona G; Mannucci E; Schulman C; Petrone L; Mansani R; Cilotti A; Balercia G; Chiarini V; Forti G; Maggi M
Eur Urol; 2006 Sep; 50(3):595-604; discussion 604. PubMed ID: 16564129
[TBL] [Abstract][Full Text] [Related]
14. Influence of demographic factors and biochemical characteristics on the prostate-specific antigen (PSA) response to testosterone replacement therapy.
Rhoden EL; Morgentaler A
Int J Impot Res; 2006; 18(2):201-5. PubMed ID: 16177827
[TBL] [Abstract][Full Text] [Related]
15. Correlation between simultaneous PSA and serum testosterone concentrations among eugonadal, untreated hypogonadal and hypogonadal men receiving testosterone replacement therapy.
Grober ED; Lamb DJ; Khera M; Murthy L; Lipshultz LI
Int J Impot Res; 2008; 20(6):561-5. PubMed ID: 18843272
[TBL] [Abstract][Full Text] [Related]
16. Impairment of couple relationship in male patients with sexual dysfunction is associated with overt hypogonadism.
Corona G; Mannucci E; Lotti F; Boddi V; Jannini EA; Fisher AD; Monami M; Sforza A; Forti G; Maggi M
J Sex Med; 2009 Sep; 6(9):2591-600. PubMed ID: 19515208
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of prostate cancer among hypogonadal men with prostate-specific antigen levels of 4.0 ng/mL or less.
Morgentaler A; Rhoden EL
Urology; 2006 Dec; 68(6):1263-7. PubMed ID: 17169647
[TBL] [Abstract][Full Text] [Related]
18. The effect of parenteral testosterone replacement on prostate specific antigen in hypogonadal men with erectile dysfunction.
Svetec DA; Canby ED; Thompson IM; Sabanegh ES
J Urol; 1997 Nov; 158(5):1775-7. PubMed ID: 9334599
[TBL] [Abstract][Full Text] [Related]
19. Factors influencing prostate-specific antigen response among men treated with testosterone therapy for 6 months.
Morgentaler A; Benesh JA; Denes BS; Kan-Dobrosky N; Harb D; Miller MG
J Sex Med; 2014 Nov; 11(11):2818-25. PubMed ID: 25131184
[TBL] [Abstract][Full Text] [Related]
20. The age-related decline of testosterone is associated with different specific symptoms and signs in patients with sexual dysfunction.
Corona G; Mannucci E; Ricca V; Lotti F; Boddi V; Bandini E; Balercia G; Forti G; Maggi M
Int J Androl; 2009 Dec; 32(6):720-8. PubMed ID: 19226406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
